1
|
Rezaeian A, Ahmadi Pishkuhi M, Oliveira Reis L, Aghamir SMK. Sexuality Transmitted Infection in the COVID-19 Pandemic and Non-Pandemic Time. Am J Mens Health 2022; 16:15579883221134900. [PMID: 36412243 PMCID: PMC9692181 DOI: 10.1177/15579883221134900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
On March 11, 2020, the World Health Organization recognized the SARS-CoV-2 infection as a pandemic. The pandemic itself in addition to its containment measures affects individuals' lifestyles and welfare including their sexual behaviors. Thus, we hypothesized that sexually transmitted infection (STI) incidence may be changed and so we evaluate urethritis incidence as the most common STI in men and some other related factors. Two cross-sectional surveys during the first 6 months of 2019 and 2020 were undertaken and data were collected from 11 urology offices located in different parts of the capital city. In total, 34,611 male participants were included in our study, and 191 (.55%) patients' clinical diagnoses were urethritis. The urethritis incidence significantly decreased from 149 of 17,950 (.83%) to 42 of 16,661 (.25%) individuals in the same period of the years 2019 and 2020, respectively (p-value < .001). There was a higher percentage of single (p-value = .049) and older (p-value < .001) urethritis patients in the first 6 months of the year 2020 compared with 2019. Our survey provided urethritis incidence, demographics, symptoms, and treatment characterization. As our results show, the proportion of urethritis patients in all populations admitted to urologist offices had dramatically decreased during the COVID-19 pandemic compared with prior. The indirect effects of the pandemic and its containment measures on people's sexual health should be noticed and an appropriate reaction and policy-making are recommended to manage issues properly in different aspects of sexual health.
Collapse
Affiliation(s)
- AhmadReza Rezaeian
- Faculty of Medicine, Shahid Beheshti
University of Medical Sciences, Tehran, Iran,Urology Research Center, Tehran
University of Medical Sciences, Tehran, Iran
| | - Mahin Ahmadi Pishkuhi
- Urology Research Center, Tehran
University of Medical Sciences, Tehran, Iran,Pars Advanced & Minimally Invasive
Medical Manners Research Center, Pars General Hospital, Iran University of Medical
Sciences, Tehran, Iran
| | - Leonardo Oliveira Reis
- UroScience and Department of Surgery
(Urology), School of Medical Sciences, University of Campinas, Unicamp, and
Pontifical Catholic University of Campinas (PUC-Campinas), Campinas, Brazil
| | - Seyed Mohammad Kazem Aghamir
- Urology Research Center, Tehran
University of Medical Sciences, Tehran, Iran,Seyed Mohammad Kazem Aghamir, Urology
Research Center, Sina Hospital, Tehran University of Medical Sciences, Hassan
Abad Sq., Imam Khomeini Ave., Tehran, Iran.
| |
Collapse
|
2
|
de Lazzari E, Martínez-Mimbrero A, Chivite I, González-Cordón A, Mosquera MM, Laguno M, Costa J, Bosch J, Blanco JL, Álvarez-Martinez M, Ugarte A, Inciarte A, de la Mora L, Torres B, Martínez-Rebollar M, Ambrosioni J, Fernaández E, Hurtado JC, Mallolas J, Miró JM, Marcos MA, Martínez E. Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections. AIDS 2022; 36:829-838. [PMID: 35013084 DOI: 10.1097/qad.0000000000003164] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To assess the impact of coronavirus disease 2019 (COVID-19) epidemics on the prevention and care for HIV and other sexually transmitted infections at a major reference centre providing preventive and clinical services in Catalonia, Spain. DESIGN We retrospectively compared anonymized clinical and laboratory data from March to December 2020 vs. 2019. METHODS Monthly clinical data on HIV preexposure and postexposure prophylaxis users and on adults with HIV infection were retrieved from the administrative hospital database. Monthly tests for HIV, hepatitis B and C, Treponema pallidum, Neisseria gonorrhoeae,and Chlamydia trachomatis, and plasma lipids and glucose were recovered from the laboratory database. RESULTS There were less (↓28%, P = 0.003) but more advanced (mean CD4+ cells/μl 305 vs. 370, P < 0.001) HIV infections and more gonorrhoea (↑39%, P < 0.001) and chlamydia (↑37%, P < 0.001) infections in 2020 vs. 2019. In people with HIV, rates of HIV RNA less than 50 copies/ml remained stable (11 vs. 11%, P = 0.147) despite less scheduled visits (↓25%, P < 0.001). However, they had less antiretroviral prescription changes (↓10%, P = 0.018), worse plasma lipids [mean total cholesterol 190 vs. 185 mg/dl, P < 0.001;mean low-density lipoprotein (LDL) cholesterol 114 vs. 110 mg/dl, P < 0.001; mean triglycerides 136 vs. 125 mg/dl, P < 0.001; mean high-density lipoprotein (HDL) cholesterol 47 vs. 48 mg/dl, P = 006], and an excess of mortality (↑264%, P = 0.006) due in great part not only to COVID-19 but also to other causes. CONCLUSION In our setting, COVID-19 epidemics was associated with an increase in some prevalent sexually transmitted infections, with less but more advanced HIV infections, and with worse nonvirologic healthcare outcomes and higher mortality in people living with HIV.
Collapse
Affiliation(s)
- Elisa de Lazzari
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | | | - Iván Chivite
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Ana González-Cordón
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Maria M Mosquera
- University of Barcelona
- Department of Microbiology, Hospital Clinic
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Montserrat Laguno
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Josep Costa
- University of Barcelona
- Department of Microbiology, Hospital Clinic
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Jordi Bosch
- University of Barcelona
- Department of Microbiology, Hospital Clinic
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Jose L Blanco
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Miriam Álvarez-Martinez
- University of Barcelona
- Department of Microbiology, Hospital Clinic
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Ainoa Ugarte
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Alexy Inciarte
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Lorena de la Mora
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Berta Torres
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Maria Martínez-Rebollar
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Juan Ambrosioni
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Emma Fernaández
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - Juan Carlos Hurtado
- Department of Microbiology, Hospital Clinic
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Josep Mallolas
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - José M Miró
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| | - María A Marcos
- University of Barcelona
- Department of Microbiology, Hospital Clinic
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Esteban Martínez
- Department of Infectious Diseases, HIV Unit, Hospital Clinic
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- University of Barcelona
| |
Collapse
|